Ciprofloxacin, tobramycin, ceftazidime, colistin, and all chemicals used for C11 and C4-HSL synthesis were obtained from Sigma-Aldrich (Saint-Quentin-Fallavier, France).
C11 [N-(2-pyrimidyl)butanamide] was prepared by condensation of butyryl chloride with 2-aminopyrimidine (in pyridine). The reaction mixture was stirred under reflux for 30 min. After the mixture was cooled at room temperature, it was filtered and the resulting solution was evaporated under reduced pressure. The crude product was washed with water and recrystallized from ethanol to obtain colorless needles with a melting point of 103°C at 60% yield. The compound was characterized by its 1H nuclear magnetic resonance (NMR) and infrared (IR) spectra.
N-(2-Pyrimidyl)butanamide: molecular weight, 165 g/mol; melting point, 103°C; 1H NMR (CDCl3), δ (parts per million) 8.63, 2H, d (J = 4.9 Hz) H4′, H6′; 8.40, 1H br, NH; 7.01 1H, t (J = 4.85 Hz) H5′; 2.75, 2H, t (J = 7.40 Hz), CH2—CO; 1.81, 2H, m, CH2; 1.05, 3H, t, CH3; IR (KBr) ν (centimeters−1): 3,400, 3,218, 3,074, 3,001, 2,961, 2,902, 2,873, 1,685, 1,583, 1,525, 1,446.
C4-HSL was synthesized following the procedure previously described (26) and was characterized by its 1H NMR and IR spectra.
All compounds tested were dissolved at the appropriate concentrations in sterile distilled water.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.